Key result
CAC scoring effectively guides primary prevention statin decisions in intermediate-risk adults.
Why the study?
Uncertainty about starting a statin for primary prevention can persist after estimating 10-year ASCVD risk with the PREVENT equations and considering risk-enhancing factors.
Does coronary artery calcium scoring improve risk stratification and guide statin therapy decisions in adults without known ASCVD at borderline or intermediate 10-year cardiovascular risk?
Does coronary artery calcium scoring improve risk stratification and guide statin therapy decisions in adults without known ASCVD at borderline or intermediate 10-year cardiovascular risk?
This clinical review outlines the 2026 ACC/AHA dyslipidemia guideline recommendations for using coronary artery calcium scoring as a decision aid to personalize statin initiation and LDL-C targets in primary prevention patients with borderline or intermediate ASCVD risk.
Answers are grounded in this paper and cite their sources.
May guide statin decisions when ASCVD risk remains uncertain after enhancers; leaves open randomized outcome trials.
Coronary artery calcium should be checked when there is uncertainty about starting a statin after you’ve estimated risk for atherosclerotic cardiovascular disease and considered risk enhancers.
No takes yet. Share an insight, caveat, or question.
Massad et al. (2026) conducted a review in Primary prevention of atherosclerotic cardiovascular disease (ASCVD) / Dyslipidemia. Coronary artery calcium (CAC) scoring vs. Standard risk estimation (PREVENT equations and risk enhancers alone) was evaluated. Coronary artery calcium scoring guides primary prevention statin therapy in intermediate-risk adults, with a score of 0 supporting deferral and scores ≥100 targeting LDL-C </dL.
Synapse has enriched 10 related papers. Consider them for comparative context: